Stay updated on ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Sign up to get notified when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.

Latest updates to the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.3 was added to the page history and the 'HHS Vulnerability Disclosure' footer link, along with the prior 'Revision: v3.3.2' note, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedA new revision entry v3.3.2 has been added to the page's revision history, replacing the previous v3.3.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedFooter shows a new Revision from v3.2.0 to v3.3.1. No study details or page content appear to be affected.SummaryDifference0.1%

- Check58 days agoChange DetectedThe government funding banner at the top of the page was removed, an administrative update that does not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check73 days agoChange DetectedThere are no substantive changes to the study record content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check101 days agoChange DetectedSummary of changes: added a government-status notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference11%

Stay in the know with updates to ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.